Coming soon European drug report 2015

What are the latest drug market trends and what are the factors driving them? What are the most recent developments in drug prevention, treatment and policy? How many new drugs were detected in Europe over the last year and what are the consequences for those using them? These and other questions will be explored by the EU drugs agency (EMCDDA) on 4 June in its annual overview of the European drug situation.

Central to the multilingual, multimedia information package is the European Drug Report 2015: Trends and Developments, a top-level analysis of the latest trends across the 28 EU Member States, Turkey and Norway. In print and online in 24 languages, the report examines: drug supply and the market; drug use and drug-related problems; and health and social responses to drug problems.

Accompanying the report will be Perspectives on drugs (PODs), online interactive articles providing insight into specific issues in the drugs field. The four themes in focus this year are: misuse of benzodiazepines among high-risk drug users; psychosocial interventions; drug consumption rooms; and heroin trafficking routes. The information package will be completed by the 2015 Statistical bulletin, containing the full European dataset underpinning the report, and Country overviews, providing national-level data and analyses.

An e-publication, including interactive maps and graphics, will be available in English. Audiovisual material will also be on offer.

Launch details

Date: Thursday 4 June 2015
Time: 10:00 Western European Time (Lisbon) (11:00 Central European Time)
Venue: Conference Centre, Praça Europa 4, Cais do Sodré, 1249-206, Lisbon
Press conference: With the presence of Dimitris Avramopoulos, European Commissioner responsible for Migration, Home Affairs and Citizenship; João Goulão, Chairman of the EMCDDA Management Board and Wolfgang Götz, EMCDDA Director.

Interviews
EMCDDA representatives will be available on the day of the launch in Lisbon to answer journalists' questions. Across Europe, staff at the Reitox national focal points will answer country-specific queries (interview details available via the link below).

Find out more
www.emcdda.europa.eu/edr2015
twitter.com/emcdda • facebook.com/emcdda • youtube.com/user/emcddatube • flickr.com/photos/emcdda • emcdda.europa.eu/rss

What are the latest drug market trends and what are the factors driving them? What are the most recent developments in drug prevention, treatment and policy? How many new drugs were detected in Europe over the last year and what are the consequences for those using them? These and other questions will be explored by the EU drugs agency (EMCDDA) on 4 June in its annual overview of the European drug situation.

Central to the multilingual, multimedia information package is the European Drug Report 2015: Trends and Developments, a top-level analysis of the latest trends across the 28 EU Member States, Turkey and Norway. In print and online in 24 languages, the report examines: drug supply and the market; drug use and drug-related problems; and health and social responses to drug problems.

 

News by year

Media support

To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:

Kathy Robertson
Head of sector
Media relations and marketing
Tel: (351) 211 21 02 00/32
Fax: (351) 211 21 03 80

Maria José Louro Bailey
Media relations assistant
Tel: (351) 211 21 02 00/40
Fax: (351) 211 21 03 80